Researchers from Boston University's Slone Epidemiology Center have found that approximately one in ten U.S. children uses one or more cough and cold medications during a given week. These findings appear in the August issue of the journal Pediatrics.
Get the full story...
Using an engineered common cold virus, UCLA researchers delivered a genetic payload to prostate cancer cells that allowed them, using Positron Emission Tomography (PET), to locate the diseased cells as they spread to the lymph nodes, the first place prostate cancer goes before invading other organs.
Get the full story...
Now that Duke University Medical Center scientists have figured out how the virus that causes cold sores hides out, they may have a way to wake it up and kill it.
Get the full story...
A new five-year study at the University of Texas Medical Branch at Galveston confirms the suspected close link between the two most common diseases of young children: colds and ear infections.
Get the full story...
A new deadly killer cold virus is spreading in USA called Adenovirus. It has many variations and the one spreading now is known as Adenovirus 14. WEBMD reports 10 Deaths from Adenovirus 14 outbreaks in four states as Adenovirus 14 cold virus becomes more common.
Get the full story...
Despite 20 years of research, the benefits of zinc lozenges as a therapy for the common cold have not been proven. A new study, published in the Sept. 1 issue of Clinical Infectious Diseases, currently available online, reviews the 14 placebo-controlled studies from the past two decades and finds significant fault with 10 of the studies.
Get the full story...
University of Newcastle researcher Kathryn Skelding, funded by the National Breast Cancer Foundation and Viralytics Ltd, has been working on a new treatment which only affects cancer cells - this would be an improvement on conventional chemotherapy and radiation treatment, which also impact on normal body cells.
Read the full story
Human rhinovirus (HRV), the leading cause of most common colds, struck two immunosuppressed lung transplant patients, leading to progressive respiratory failure, graft dysfunction and death.
Read the full story